Study Period | |||||
---|---|---|---|---|---|
Enrolment | Allocation | Follow-up | |||
Timepoint | - t1 | 0 | t 1 : 1 month | t 2 : 6 months | t 3 : 18 months - Close-out |
Enrolment: | |||||
Eligibility screen | X | ||||
Information to patients/careviger | X | ||||
Collection of non-opposition to participate | X | ||||
Randomized allocation | X | ||||
Intervention: | |||||
(1) Intervention: Optimization of drug prescribing | X | X | X | ||
(2) Control | |||||
Assessments: | |||||
Collected in patient record: * Sociodemographic data * Diagnosis and stage * Current comorbidities, history of comorbidities, lifestyle habits * Biological exam and artrial pressure when available | X | ||||
Primary outcomes: * IADL scale * DAD-6 scale | X | X | X | X | |
Secondary outcomes: * MMSE (cognitive function) * mini-GDS (depression) * Hamilton scale (anxiety) * Pain scale * EUROQOL-5D (quality of life) * Girerd scale (compliance to drug prescribing) * Event and date of event: hospitalization, falls, recourse of emergency, institutionalization, death | X | X | X | ||
Drugs prescribing | X | X | X | X |